Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001948439 | SCV002204756 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2W | 2022-11-15 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with LIMS2-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LIMS2 protein function. ClinVar contains an entry for this variant (Variation ID: 1430796). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 202 of the LIMS2 protein (p.Leu202Pro). |
Ambry Genetics | RCV004935226 | SCV005608097 | uncertain significance | not specified | 2024-10-06 | criteria provided, single submitter | clinical testing | The c.611T>C (p.L204P) alteration is located in exon 6 (coding exon 6) of the LIMS2 gene. This alteration results from a T to C substitution at nucleotide position 611, causing the leucine (L) at amino acid position 204 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |